In a hurry? Here’s a quick summary…
- The Pharmacy and Poisons Board alerts the public to a counterfeit batch of Herceptin 440mg drugs found in Kenya, urging against its use due to safety concerns.
- PPB takes legal action and enhances market surveillance, emphasizing the importance of reporting any suspicious medical products for public safety.
The Pharmacy and Poisons Board (PPB) has issued a public alert regarding a batch of counterfeit Herceptin 440mg (Trastuzumab 440mg) drugs, vital in treating breast and stomach cancer, recently discovered in the Kenyan market.
This specific batch, identified by the number C5830083, falsely claims to be manufactured in Germany by Roche Products Ltd, with production and expiry dates of 12/2021 and 11/2024, respectively.
PPB, through a notice released on Saturday, confirmed the falsification of batch C5830083, emphasizing its unauthorized presence in the market due to discrepancies in contents, packaging, and labeling as verified by the brand owner.
Read Also:
Mathare United Clashes With Naivas in a High-Stakes Match
Ongoing Strike by Clinical Officers and Lab Technicians Leaves Patients Stranded
Nairobi County Assembly Calls for Disbandment of Housing Committee Over Building Approval Concerns
Consequently, the board strongly advises against any usage, distribution, sale, or supply of this counterfeit product, citing significant doubts regarding its safety, quality, and efficacy.
In response to the discovery, PPB, in coordination with government investigative bodies, has initiated legal and regulatory measures against suspected individuals involved in the distribution of the counterfeit drugs.
The board has also heightened surveillance across the market to ensure public health and safety, promising swift action to protect consumers.
Assuring the public of continuous vigilance, PPB highlights its robust market surveillance and control systems, emphasizing the ongoing monitoring of medical product quality and safety within Kenya.
Read Also:
Fatal Crash Claims Lives of Four Family Members on Bomet-Olenguruone Highway
‘I Lost About 90% Of My Friends Due To Wrongful Link To Kiptum’s Accident’-Kipchoge
Additionally, the board encourages both the public and healthcare providers to promptly report any suspicions regarding the presence of substandard, falsified, or suspicious medical products to the agency, underscoring collective efforts in safeguarding public health.